Special Issue "Recent Advances in Antivirals for Emerging Viruses"
Deadline for manuscript submissions: closed (28 February 2021).
Interests: antiviral research; arbovirology; molecular virology; natural products for drug discovery; infectious disease; molecular epidemiology; cancer research
The emergence of Covid-19 is a reminder that new transmissible viruses have a potential global social, health, and economic impact. Current biological tools (including rapid and efficient cloning and sequencing) have advanced basic scientific efforts to identify viral enzymes of important novel and re-emerging human viruses (e.g., Dengue, West Nile, Zika, Chikungunya, Influenza, and now Coronaviruses). At the same time, drug discovery has exponentially expanded, resulting in vast libraries of compounds for screening direct antiviral activity. This Special issue will highlight recent advances in antiviral drug developments, including:
1) direct acting antivirals;
2) modifiers of immune activation;
3) inhibitors of specific cell activation pathways.
Dr. Keivan Zandi
Dr. James J. Kohler
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antiviral agents
- broad-spectrum antivirals
- antiviral response
- emerging and re-emerging viral diseases
- antiviral strategies
- druggable antiviral targets
- direct acting antivirals
- host-directed antivirals
- drug-resistant viruses